Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M702Revenue $M165Net Margin (%)-10.6Z-Score2.4
Enterprise Value $M369EPS $-0.4Operating Margin %-4.8F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-10.4Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %0Quick Ratio6.3Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %-24.3Current Ratio6.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-6.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-9.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.9ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIJohn Burbank 2014-06-30 Sold Out -0.01%$8.6 - $12.67
($10.38)
$ 14.4228%Sold Out0
INFIJohn Burbank 2014-03-31 Buy 0.01%$11.37 - $16.52
($13.45)
$ 14.427%New holding16,556
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 14.42-115%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 14.42-174%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 14.42-75%New holding75,000
INFIJean-Marie Eveillard 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 14.4211%Sold Out0
INFIJean-Marie Eveillard 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 14.4245%Reduce -54.94%180,000
INFIJean-Marie Eveillard 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 14.4245%Reduce -25.85%464,241
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 14.4257%Reduce -63.91%7,415
INFIJean-Marie Eveillard 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 14.4257%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 14.4262%Reduce -25.39%20,545
INFIJean-Marie Eveillard 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 14.4254%Add 566.95%281,460
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 14.4245%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-9.69view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-12.42view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-2.56view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-2.56view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-11.46view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-3.67view
EVNIN ANTHONY BDirector 2014-09-30Sell112,451$13.566.56view
Palombella Vito J.Chief Scientific Officer 2014-09-03Sell9,472$15.39-6.11view
Palombella Vito J.Chief Scientific Officer 2014-07-01Sell879$12.8712.28view
Palombella Vito J.Chief Scientific Officer 2014-02-25Sell4,736$15-3.67view

Press Releases about INFI :

    Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com
    own Mar 02 2015 
    comment on INFI Mar 02 2013 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
    Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

    More From Other Websites
    Why Infinity Pharmaceuticals (INFI) Could Be Positioned for a Surge? - Tale of the Tape Mar 12 2015
    Infinity Provides Company Update and Reports Full-Year 2014 Financial Results Mar 10 2015
    4 Biotechs Expected to See Huge Buying on PowerShares Rebalance Mar 03 2015
    JPM Securities Picks Through Biotech News For Winners Feb 25 2015
    Infinity reports 4Q loss Feb 24 2015
    Infinity reports 4Q loss Feb 24 2015
    Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Feb 24 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Feb 24 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 24 2015
    Infinity Provides Company Update and Reports Full-Year 2014 Financial Results Feb 24 2015
    Q4 2014 Infinity Pharmaceuticals Inc Earnings Release - After Market Close Feb 24 2015
    Infinity to Present at the RBC Capital Markets 2015 Healthcare Conference Feb 18 2015
    Infinity to Present at the RBC Capital Markets 2015 Healthcare Conference Feb 18 2015
    Not Too Late to Ride on Q4 Earnings: 3 Biotech Picks - Earnings ESP Feb 17 2015
    Interim Management Statement Feb 16 2015
    Infinis Energy plc Interim Management Statement Feb 16 2015
    Infinity Announces the Date of Its Full-Year 2014 Financial Results Conference Call and Webcast Feb 10 2015
    Will Thoratec (THOR) Miss Earnings Estimates in Q4? - Analyst Blog Feb 06 2015
    Infinity Provides Key 2015 Goals and Financial Guidance Jan 14 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK